Roche follows Shire to Europe with hemophilia approval for Hemlibra
admin 26th January 2018 Uncategorised 0Roche and Shire are taking their hemophilia battle across the pond. Following Shire’s EU approval for Adynovi last week, Roche has nabbed a European green light for Hemlibra, a first-in-class hemophilia A medication that analysts expect to reach blockbuster heights.
More: Roche follows Shire to Europe with hemophilia approval for Hemlibra
Source: fierce